Literature DB >> 24559482

Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.

Martha L Bustos1, Luai Huleihel, Maria G Kapetanaki, Christian L Lino-Cardenas, Lyle Mroz, Bryon M Ellis, Bryan J McVerry, Thomas J Richards, Naftali Kaminski, Nayra Cerdenes, Ana L Mora, Mauricio Rojas.   

Abstract

RATIONALE: Aging is characterized by functional impairment and reduced capacity to respond appropriately to environmental stimuli and injury. With age, there is an increase in the incidence and severity of chronic and acute lung diseases. However, the relationship between age and the lung's reduced ability to repair is far from established and necessitates further research in the field.
OBJECTIVES: Little is currently known about age-related phenomena in mesenchymal stem cells (MSCs). On account of their ability to protect the endothelium and the alveolar epithelium through multiple paracrine mechanisms, we looked for adverse effects that aging might cause in MSC biology. Such age-related changes might partly account for the increased susceptibility of the aging lung to injury.
MEASUREMENTS AND MAIN RESULTS: We demonstrated that old mice have more inflammation in response to acute lung injury. To investigate the causes, we compared the global gene expression of aged and young bone marrow-derived MSCs (B-MSCs). Our results revealed that the expression levels of inflammatory response genes depended on the age of the B-MSCs. We demonstrated that the age-dependent decrease in expression of several cytokine and chemokine receptors is important for the migration and activation of B-MSCs. Finally, we showed by adoptive transfer of aged B-MSCs to young endotoxemic mice that aged cells lacked the antiinflammatory protective effect of their young counterparts.
CONCLUSIONS: Taken together, the decreased expression of cytokine and chemokine receptors in aged B-MSCs compromises their protective role by perturbing the potential of B-MSCs to become activated and mobilize to the site of injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24559482      PMCID: PMC4061541          DOI: 10.1164/rccm.201306-1043OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  78 in total

1.  IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice.

Authors:  Kuang-Yao Yang; Hsin-Chin Shih; Chorng-Kuang How; Cheng-Yu Chen; Han-Shui Hsu; Ching-Wen Yang; Yu-Chin Lee; Reury-Perng Perng; Chi-Hsien Peng; Hsin-Yang Li; Chia-Ming Chang; Chung-Yuan Mou; Shih-Hwa Chiou
Journal:  Chest       Date:  2011-08-11       Impact factor: 9.410

2.  Inhibitory effect of statins on renal epithelial-to-mesenchymal transition.

Authors:  Sharmila Patel; Roger M Mason; Jun Suzuki; Atsushi Imaizumi; Takashi Kamimura; Zhi Zhang
Journal:  Am J Nephrol       Date:  2006-07-26       Impact factor: 3.754

3.  Cell-based therapy for acute lung injury: are we there yet?

Authors:  Jae-Woo Lee; Yinggang Zhu; Michael A Matthay
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

Review 4.  Immunomodulatory properties and therapeutic application of mesenchymal stem cells.

Authors:  M Shi; Z-W Liu; F-S Wang
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

5.  Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.

Authors:  Yutong Zhao; Jing Zhao; Rachel K Mialki; Jianxin Wei; Ernst W Spannhake; Ravi Salgia; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

6.  Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice.

Authors:  Jianguo Xu; Edilson T Gonzalez; Smita S Iyer; Valerie Mac; Ana L Mora; Roy L Sutliff; Alana Reed; Kenneth L Brigham; Patricia Kelly; Mauricio Rojas
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-04-09       Impact factor: 6.053

7.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis.

Authors:  Yibin Deng; Xiaoyang Ren; Lin Yang; Yahong Lin; Xiangwei Wu
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

8.  Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels.

Authors:  Martha L Bustos; Luai Huleihel; Ernest M Meyer; Albert D Donnenberg; Vera S Donnenberg; Joseph D Sciurba; Lyle Mroz; Bryan J McVerry; Bryon M Ellis; Naftali Kaminski; Mauricio Rojas
Journal:  Stem Cells Transl Med       Date:  2013-10-02       Impact factor: 6.940

9.  Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.

Authors:  Donna M Wilcock; Dave Morgan; Marcia N Gordon; Tiffany L Taylor; Lisa A Ridnour; David A Wink; Carol A Colton
Journal:  J Neuroinflammation       Date:  2011-09-09       Impact factor: 8.322

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  78 in total

Review 1.  What's new in cell therapies in ARDS?

Authors:  Shahd Horie; Gerard F Curley; John G Laffey
Journal:  Intensive Care Med       Date:  2015-12-01       Impact factor: 17.440

Review 2.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 3.  Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.

Authors:  Mauricio Rojas; Ana L Mora; Maria Kapetanaki; Nathaniel Weathington; Mark Gladwin; Oliver Eickelberg
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 4.  Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues.

Authors:  Huijuan Liu; Xuechun Xia; Baojie Li
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-18

5.  Study of Bone Marrow and Embryonic Stem Cell-Derived Human Mesenchymal Stem Cells for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice.

Authors:  Qi Hao; Ying-Gang Zhu; Antoine Monsel; Stephane Gennai; Travis Lee; Fengyun Xu; Jae-Woo Lee
Journal:  Stem Cells Transl Med       Date:  2015-05-21       Impact factor: 6.940

6.  * CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments.

Authors:  Niloofar Farhang; Jonathan M Brunger; Joshua D Stover; Pratiksha I Thakore; Brandon Lawrence; Farshid Guilak; Charles A Gersbach; Lori A Setton; Robby D Bowles
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

7.  Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.

Authors:  Susumu Yamaguchi; Nobutaka Horie; Katsuya Satoh; Takeshi Ishikawa; Tsuyoshi Mori; Hajime Maeda; Yuhtaka Fukuda; Shunsuke Ishizaka; Takeshi Hiu; Yoichi Morofuji; Tsuyoshi Izumo; Noriyuki Nishida; Takayuki Matsuo
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-15       Impact factor: 6.200

8.  Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.

Authors:  Jun Tashiro; Sharon J Elliot; David J Gerth; Xiaomei Xia; Simone Pereira-Simon; Rhea Choi; Paola Catanuto; Shahriar Shahzeidi; Rebecca L Toonkel; Rahil H Shah; Fadi El Salem; Marilyn K Glassberg
Journal:  Transl Res       Date:  2015-09-18       Impact factor: 7.012

9.  Alpha-Klotho Enrichment in Induced Pluripotent Stem Cell Secretome Contributes to Antioxidative Protection in Acute Lung Injury.

Authors:  Amiq Gazdhar; Priya Ravikumar; Johanne Pastor; Manfred Heller; Jianfeng Ye; Jianning Zhang; Orson W Moe; Thomas Geiser; Connie C W Hsia
Journal:  Stem Cells       Date:  2017-12-25       Impact factor: 6.277

10.  Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.

Authors:  Michael C W Chan; Denise I T Kuok; Connie Y H Leung; Kenrie P Y Hui; Sophie A Valkenburg; Eric H Y Lau; John M Nicholls; Xiaohui Fang; Yi Guan; Jae W Lee; Renee W Y Chan; Robert G Webster; Michael A Matthay; J S Malik Peiris
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.